Your Guide to Health, Wellness, and Sustainable Weight Loss

No Smoking Day: How GLP-1 Injections May Support Both Quitting Smoking and Losing Weigh

How to Break a Weight Loss Plateau

March marks No Smoking Day in the UK—a national moment of reflection and a powerful call to action for those thinking about quitting smoking. While the goal is clear—to stop smoking and start living healthier—many don’t realise that this day also opens the door to another health opportunity: managing weight more effectively, especially with the help of GLP-1 weight loss injections, such as Wegovy and Mounjaro.

At Weight Medics, we understand the challenges of both quitting smoking and controlling weight. What’s exciting is that recent research suggests these journeys may not be separate—they may actually complement each other, especially with modern medical treatments.

Why Smoking Cessation and Weight Management Are Connected

One of the lesser-discussed side effects of quitting smoking is weight gain. For many, the fear of gaining weight becomes a barrier to quitting. That’s where GLP-1 medications come in. These treatments, primarily used for medical weight loss, have shown early promise in helping reduce nicotine cravings as well.

GLP-1 (Glucagon-like peptide-1) receptor agonists like semaglutide (Wegovy) and tirzepatide (Mounjaro) work by regulating appetite and reward pathways in the brain. This effect not only supports sustained weight loss but may also help reduce addictive behaviors—including smoking.


The Life-Changing Health Benefits of Quitting Smoking
If you're considering quitting smoking, the benefits are immense and start almost immediately:

  • Improved lung function and easier breathing

  • Better cardiovascular health

  • Reduced risk of cancer, stroke, and heart disease

  • Enhanced energy and sleep quality

  • Renewed enjoyment of food, taste, and smell

According to research, up to two-thirds of smokers may die from smoking-related illness. But the good news is, quitting significantly improves both life expectancy and quality of life, even if you've smoked for years.

How GLP-1 Weight Loss Injections Like Wegovy and Mounjaro Might Help

In addition to weight loss, patients using GLP-1 medications often report reduced cravings—not just for food, but for smoking too. Early studies and anecdotal evidence suggest a dual benefit:

Appetite suppression, helping to avoid post-quitting weight gain

Dampened craving cycles, which may make it easier to resist the urge to smoke
While these medications are not yet licensed specifically for smoking cessation, the emerging science is promising and under ongoing research.

Supporting You on No Smoking Day and Beyond


At Weight Medics, we go beyond basic advice. Our doctor-led programmes are designed to support your full health journey—whether you're trying to quit smoking, lose weight, or ideally, both.

We offer personalised plans that include:

  • Comprehensive health assessments

  • Access to prescription GLP-1 injections such as Wegovy and Mounjaro

  • Ongoing support from medical professionals

  • Nutritional and behavioural guidance

Quitting smoking is hard. Managing weight can be too. But you don’t have to do it alone.

Take the First Step Towards a Healthier You

This No Smoking Day, we encourage you to take that courageous first step. And if you’re worried about managing weight after quitting, know that there is medical help available. GLP-1 medications could provide the added support needed to make this change more achievable.

Each cigarette you don’t light is a powerful step toward a longer, healthier life—and a life where you feel truly in control of your body and wellbeing.

Frequently Asked Questions
  • Are GLP-1 and GIP injections effective for quitting smoking?

    GLP1 Wegovy (semaglutide) and GIP Mounjaro (tirzepatide) injections are not currently licensed as smoking-cessation treatments. But first studies reveal good results. GLP-1 (GIP) medications influence the brain’s reward and craving pathways, which may help reduce nicotine cravings in some individuals.

  • Which clinics in the UK offer GLP-1 and GIP injections for smoking cessation?

    Since GLP1 Wegovy (semaglutide) and GIP Mounjaro (tirzepatide) medications are not approved specifically for smoking cessation, UK clinics, including Weight Medics, prescribe them for medical weight loss only.

  • What are the top-rated GLP-1 and GIP injection treatments for smoking cessation?

    At present, no GLP-1 and GIP injections are formally rated or licensed for smoking cessation. However, when used for weight management, Wegovy (semaglutide) and Mounjaro (tirzepatide) are most commonly associated with reduced cravings.

  • Can I buy GLP-1 and GIP injection kits online for smoking cessation in the UK?

    You can purchase GLP1 Wegovy (semaglutide) and GIP Mounjaro (tirzepatide) online in the UK, but only with a valid prescription and strictly for licensed uses, such as weight loss. Reputable, GPhC-regulated or CQC-registered online clinics, including Weight Medics, provide clinician assessments before prescribing.

  • How do GLP-1 and GIP injections help reduce nicotine cravings?

    GLP1 Wegovy (semaglutide) and GIP Mounjaro (tirzepatide) drugs work on brain receptors that affect appetite, impulses, and the reward system. These are the same brain (GIP) pathways that are connected to nicotine addiction. GLP1 Wegovy (semaglutide) and GIP Mounjaro (tirzepatide) therapies may help reduce the desire to smoke and lower the pleasure that comes with smoking by changing how dopamine works and slowing down wanting cycles.

  • Are there any side effects of using GLP-1 and GIP injections to stop smoking?

    Yes. GLP1 Wegovy (semaglutide) and GIP Mounjaro (tirzepatide) injections carry the same side-effect profile, regardless of whether someone is quitting smoking. Common side effects include nausea, bloating, constipation, fatigue, and headaches. These side effects are usually temporary and dose-dependent.

Book Now

References

NHS – Stop Smoking Services
Action on Smoking and Health (ASH)
GLP-1 Receptor Agonists: Implications for Addiction
Wegovy (Semaglutide) Summary – EMA
Public Health England – Smoking and Obesity Links

Overview